Status:
COMPLETED
Whole Body MRI With DWI for Monitoring Patients Treated for Testicular Cancer Stage II-III
Lead Sponsor:
Aarhus University Hospital
Conditions:
Testicular Neoplasm
Eligibility:
MALE
18+ years
Phase:
NA
Brief Summary
Testicular cancer (TC) affects approx. 1% of Danish men and is the most common cancer in men aged 15-35 years. It is the most curable solid cancer type with a 5-year survival rate of 90-95%. Staging a...
Detailed Description
AIMS AND HYPOTHESES The overall aim of this study is to reduce the risk of radiation-induced secondary cancers in patients operated for testicular cancer (TC) by replacing computed tomography (CT) as...
Eligibility Criteria
Inclusion
- Newly diagnosed TC stage II-III disease or
- Previously TC stage I disease with new spread of disease during surveillance
Exclusion
- Age \< 18 years
- Claustrophobia or unable to fit inside the bore of the MRI-scanner
- Foreign metal objects contraindicating a 1.5T MRI including pacemaker
Key Trial Info
Start Date :
February 19 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 1 2021
Estimated Enrollment :
90 Patients enrolled
Trial Details
Trial ID
NCT03436901
Start Date
February 19 2018
End Date
October 1 2021
Last Update
January 3 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Aarhus University Hospital, Dept Radiology
Aarhus, Denmark, 8200